MYD88 and breast carcinoma: Studies in humans have shown that MyD88 mediates colorectal cancer cell proliferation, migration and invasion via NF-κB/AP-1 signaling pathway [103] and TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells [95].